From: Peculiar characteristics of new-onset Type 1 Diabetes during COVID-19 pandemic
Spearman Correlation | Multiple regression analysis | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Whole population | Group I | Group II | Group I | Group II | ||||||
Beta | P | Beta | P | Beta | P | Beta | P | Beta | P | |
Age (years) | 0.09 | 0.20 | 0.02 | 0.79 | 0.26 | 0.10 | ||||
Weight-SDS | 0.28 | < 0.001 | 0.24 | 0.005 | 0.24 | 0.13 | 0.32 | 0.04 | -0.08 | 0.70 |
Height-SDS | 0.12 | 0.11 | 0.07 | 0.39 | 0.12 | 0.44 | ||||
BMI-SDS | 0.19 | 0.01 | 0.14 | 0.09 | 0.21 | 0.19 | -0.29 | 0.06 | 0.09 | 0.61 |
Glycemia (mg/dL) | -0.28 | < 0.001 | -0.23 | 0.007 | -0.47 | 0.002 | -0.14 | 0.24 | -0.14 | 0.43 |
HbA1c (mmol/mol) | -0.33 | < 0.001 | -0.40 | < 0.001 | -0.37 | 0.01 | -0.15 | 0.25 | -0.14 | 0.37 |
C-peptide (ng/mL) | 0.35 | < 0.001 | 0.33 | 0.001 | 0.31 | 0.04 | 0.25 | 0.05 | 0.41 | 0.008 |
GAD Ab (U/ml) | -0.01 | 0.90 | -0.04 | 0.61 | 0.06 | 0.73 | ||||
IA2 Ab (U/ml) | -0.12 | 0.15 | -0.15 | 0.11 | -0.15 | 0.35 | ||||
TSH (µUI/ml) | -0.07 | 0.37 | -0.10 | 0.29 | -0.14 | 0.36 | ||||
FT4 (ng/dL) | 0.04 | 0.63 | -0.09 | 0.34 | -0.10 | 0.53 | ||||
Total Cholesterol (mg/dL) | 0.01 | 0.88 | 0.04 | 0.63 | 0.014 | 0.93 | ||||
HDL Cholesterol (mg/dL) | 0.11 | 0.23 | -0.002 | 0.96 | 0.36 | 0.03 | 0.054 | 0.67 | 0.54 | 0.01 |
LDL Cholesterol (mg/dL) | 0.08 | 0.46 | 0.16 | 0.31 | 0.19 | 0.27 | ||||
Tryglicerides (mg/dL) | -0.15 | 0.07 | -0.03 | 0.72 | -0.43 | 0.009 | -0.05 | 0.65 | -1.84 | 0.01 |
TG/HDL ratio | -0.23 | 0.01 | -0.16 | 0.89 | -0.51 | 0.002 | -0.06 | 0.6 | 1.78 | 0.03 |